Literature DB >> 3071457

Ketanserin, an effective third-line agent in primary hypertension.

J J Murphy1, P H Whincup, S E Gould, R G Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3071457     DOI： 10.2165/00003495-198800361-00027

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  10 in total

1.  Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.

Authors:  C Beretta-Piccoli; R Amstein; O Bertel; H R Brunner; F R Bühler; F Follath; M Solèr; M Vallotton
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 2.  The rationale for ketanserin therapy in hypertension.

Authors:  L Hansson; T Hedner
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics.

Authors:  L J Beilin; C J Bulpitt; E C Coles; C T Dollery; J S Gear; G Harper; B F Johnson; A D Munro-Faure; S C Turner
Journal:  Br Heart J       Date:  1980-01

4.  Propranolol in the treatment of essential hypertension.

Authors: 
Journal:  JAMA       Date:  1977-05-23       Impact factor: 56.272

5.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

6.  Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.

Authors:  L E Ramsay; L Parnell; P C Waller
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

7.  "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

8.  Chronic effect of ketanserin in mild to moderate essential hypertension.

Authors:  A J Woittiez; G J Wenting; A H van den Meiracker; H J Ritsema van Eck; A J Man in't Veld; F A Zantvoort; M A Schalekamp
Journal:  Hypertension       Date:  1986-02       Impact factor: 10.190

9.  Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.

Authors:  P C Waller; S A Solomon; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

10.  Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.